{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:48:30Z","timestamp":1759402110900,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vaccine.2017.10.071","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T18:47:30Z","timestamp":1511376450000},"page":"427-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015"],"prefix":"10.1016","volume":"36","author":[{"given":"Bruce G.","family":"Weniger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian E.","family":"Anglin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pensiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey K.","family":"Pullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.10.071_b0005","series-title":"Vaccines","first-page":"1200","article-title":"Alternative vaccine delivery methods [Chapter 61]","author":"Weniger","year":"2013"},{"key":"10.1016\/j.vaccine.2017.10.071_b0010","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.vaccine.2013.05.048","article-title":"Cutaneous vaccination: antigen delivery into or onto the skin","volume":"31","author":"Weniger","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.10.071_b0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.coi.2011.03.008","article-title":"Electroporation delivery of DNA vaccines: prospects for success","volume":"23","author":"Sardesai","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.10.071_b0020","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/jit236","article-title":"Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery","volume":"208","author":"Kalams","year":"2013","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.10.071_b0025","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/mt.2014.245","article-title":"Synthetic consensus HIV-1 DNA induces potent cellular immune responses and synthesis of Granzyme B, Perforin in HIV infected individuals","volume":"23","author":"Morrow","year":"2015","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2017.10.071_b0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/hgtb.2015.020","article-title":"Skin transfection patterns and expression kinetics of electroporation-enhanced plasmid delivery using the CELLECTRA-3P, a portable next-generation dermal electroporation device","volume":"26","author":"Amante","year":"2015","journal-title":"Hum Gene Ther Methods"},{"key":"10.1016\/j.vaccine.2017.10.071_b0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2013.00354","article-title":"Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants","volume":"4","author":"Flingai","year":"2013","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.10.071_b0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/infdis\/jiv496","article-title":"Vaccination with heterologous HIV-1 envelope sequences and heterologous adenovirus vectors increases T-cell responses to conserved regions: HVTN 083","volume":"213","author":"Walsh","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.10.071_b0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/infdis\/jiu003","article-title":"Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles","volume":"210","author":"Goepfert","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.071_b0050","doi-asserted-by":"crossref","unstructured":"Kutzler MA, Wise MC, Hutnick NA, et al. Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge. Mucosal Immunol 2016;9(1):13\u201323 <http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4636490, https:\/\/doi.org\/10.1038\/mi.2015.31>.","DOI":"10.1038\/mi.2015.31"},{"key":"10.1016\/j.vaccine.2017.10.071_b0055","unstructured":"Bagarazzi ML1, Yan J, Morrow MP, et al. Immunotherapy against HPV16\/18 generates potent TH1 and cytotoxic cellular immune responses. Sci Transl Med 2012;4(155):155ra138 <http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4317299, https:\/\/doi.org\/10.1126\/scitranslmed.3004414>."},{"issue":"10008","key":"10.1016\/j.vaccine.2017.10.071_b0060","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial","volume":"386","author":"Trimble","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2017.10.071_b0065","doi-asserted-by":"crossref","first-page":"e19252","DOI":"10.1371\/journal.pone.0019252","article-title":"In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers","volume":"6","author":"Vasan","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vaccine.2017.10.071_b0070","doi-asserted-by":"crossref","first-page":"e0134287","DOI":"10.1371\/journal.pone.0134287","article-title":"A phase I double blind, placebo-controlled, randomized study of the safety and immunogenicity of electroporated HIV DNA with or without interleukin 12 in prime-boost combinations with an Ad35 HIV vaccine in healthy HIV-seronegative African adults","volume":"10","author":"Mpendo","year":"2015","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.vaccine.2017.10.071_b0075","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1016\/j.vaccine.2015.07.013","article-title":"Effect of jet injection on infectivity of measles, mumps, and rubella vaccine in a bench model","volume":"33","author":"Coughlin","year":"2015","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2017.10.071_b0080","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1016\/j.vaccine.2015.03.074","article-title":"A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Gu\u00e9rin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe","volume":"33","author":"Geldenhuys","year":"2015","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2017.10.071_b0085","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1016\/j.vaccine.2015.06.071","article-title":"Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: association between injection quality and immunogenicity","volume":"33","author":"Resik","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.071_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.02.014","article-title":"Mucosal vaccine delivery: current state and a pediatric perspective","author":"Shakya","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.10.071_b0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2014.08.010","article-title":"Pollen grains for oral vaccination","volume":"194","author":"Atwe","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.10.071_b0100","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s11095-014-1335-1","article-title":"Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity","volume":"31","author":"Ma","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2017.10.071_b0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2014.06.048","article-title":"Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery","volume":"189","author":"McCarthy","year":"2014","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.vaccine.2017.10.071_b0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11095-010-0169-8","article-title":"Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique","volume":"28","author":"Donnelly","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2017.10.071_b0115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2016.02.023","article-title":"Transcending epithelial and intracellular biological barriers; a prototype DNA delivery device","volume":"226","author":"McCaffrey","year":"2016","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.vaccine.2017.10.071_b0120","first-page":"21","article-title":"Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen","volume":"56","author":"Lin","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2017.10.071_b0125","series-title":"Transdermal and intradermal delivery of therapeutic agents: application of physical technologies","first-page":"309","author":"Banga","year":"2011"},{"key":"10.1016\/j.vaccine.2017.10.071_b0130","series-title":"Therapeutic peptides and proteins: formulation, processing, and delivery systems","first-page":"400","author":"Banga","year":"2015"},{"key":"10.1016\/j.vaccine.2017.10.071_b0135","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jconrel.2014.08.006","article-title":"Micro-fractional epidermal powder delivery for improved skin vaccination","volume":"192","author":"Chen","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.10.071_b0140","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1038\/ncomms5447","article-title":"A micro-sterile inflammation array as an adjuvant for influenza vaccines","volume":"5","author":"Wang","year":"2014","journal-title":"Nat. Commun"},{"issue":"16","key":"10.1016\/j.vaccine.2017.10.071_b0145","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1073\/pnas.1500408112","article-title":"Effective and lesion-free cutaneous influenza vaccination","volume":"112","author":"Wang","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.10.071_b0150","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","article-title":"Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine","volume":"19","author":"Roy","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.071_b0155","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.vaccine.2005.08.012","article-title":"Epidermal DNA vaccine for influenza is immunogenic in humans","volume":"24","author":"Drape","year":"2006","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2017.10.071_b0160","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2009.02.061","article-title":"DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial","volume":"2009","author":"Jones","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.071_b0165","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/JVI.76.7.3309-3317.2002","article-title":"Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine","volume":"76","author":"Fuller","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.071_b0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymeth.2006.05.022","article-title":"Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases","volume":"40","author":"Fuller","year":"2006","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2017.10.071_b0175","doi-asserted-by":"crossref","first-page":"e33715","DOI":"10.1371\/journal.pone.0033715","article-title":"Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques","volume":"7","author":"Fuller","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.10.071_b0180","unstructured":"Clements-Mann ML. Lessons for AIDS vaccine development from non-AIDS vaccines. AIDS Res Hum Retroviruses Oct 1998;14(Suppl3):S197\u2013203 <http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9814944>."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:23:15Z","timestamp":1759400595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17314792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0264410X17314792"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}